SGLT2 versus DPP4 inhibitors for type 2 diabetes

被引：16
|
作者：
Scheen, Andre J. [1 ,2 ]
机构：
[1] CHU Sart Tilman, Dept Med, Div Diabet Nutr & Metab Disorders, B-4000 Liege, Belgium
[2] CHU Sart Tilman, Dept Med, Clin Pharmacol Unit, B-4000 Liege, Belgium
来源：
LANCET DIABETES & ENDOCRINOLOGY | 2013年 / 1卷 / 03期
关键词：
CANAGLIFLOZIN;
D O I：
10.1016/S2213-8587(13)70095-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：168 / 170
页数：4
相关论文
共 50 条
  • [21] In type 2 diabetes, SGLT2 inhibitors were linked to diabetic ketoacidosis vs. DPP-4 inhibitors
    Liakos, Aris
    Tsapas, Apostolos
    Bekiari, Eleni
    [J]. ANNALS OF INTERNAL MEDICINE, 2020, 173 (12) : JC70 - JC70
  • [22] Polyarthropathy in type 2 diabetes patients treated with DPP4 inhibitors
    Saito, Tatsuhiko
    Ohnuma, Kei
    Suzuki, Hiroshi
    Dang, Nam H.
    Hatano, Ryou
    Ninomiya, Hiroki
    Morimoto, Chikao
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2013, 102 (01) : E8 - E12
  • [23] SGLT2 inhibitors in the treatment of type 2 diabetes
    Hasan, Farhad M.
    Alsahli, Mazen
    Gerich, John E.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 104 (03) : 297 - 322
  • [24] SGLT2 inhibitors in the management of type 2 diabetes
    Reddy, R. P. Monica
    Inzucchi, Silvio E.
    [J]. ENDOCRINE, 2016, 53 (02) : 364 - 372
  • [25] SGLT2 inhibitors in the management of type 2 diabetes
    R. P. Monica Reddy
    Silvio E. Inzucchi
    [J]. Endocrine, 2016, 53 : 364 - 372
  • [26] EFFECTS OF SGLT-2 INHIBITORS VERSUS DPP-4 INHIBITORS ON ANEMIA IN PATIENTS WITH TYPE 2 DIABETES
    Yang, Ai-Yu
    Chen, Hung-Chun
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I1007 - I1008
  • [27] SGLT2 Inhibitors in Type 2 Diabetes Mellitus
    Ferrannini, Giulia
    Savarese, Gianluigi
    Cosentino, Francesco
    [J]. HEART FAILURE CLINICS, 2022, 18 (04) : 551 - 559
  • [28] Lower risk of gout in sodium glucose cotransporter 2 (SGLT2) inhibitors versus dipeptidyl peptidase-4 (DPP4) inhibitors in type-2 diabetes patients: a propensity score-matched study
    Chou, O. H., I
    Liu, X.
    Zhou, J.
    Jing, F.
    Li, L.
    Lee, S.
    Wong, W. T.
    Zhang, Q.
    Chang, C.
    Liu, T.
    Tse, G.
    Cheung, B. M. Y.
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 : 2681 - 2681
  • [29] Preconception SGLT2 or DPP4 inhibitor use and adverse pregnancy outcomes
    Ray, Joel G.
    Harel, Ziv
    Gilbert, Richard E.
    Wald, Ron
    Berger, Howard
    Park, Alison L.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 205
  • [30] Comparison of SGLT2 inhibitors vs. DPP4 inhibitors for patients with metabolic dysfunction associated fatty liver disease and diabetes mellitus
    Y. Suzuki
    H. Kaneko
    A. Okada
    R. Ohno
    I. Yokota
    K. Fujiu
    T. Jo
    N. Takeda
    H. Morita
    K. Node
    H. Yasunaga
    I. Komuro
    [J]. Journal of Endocrinological Investigation, 2024, 47 : 1261 - 1270
12345